SCHEMBL8796929

SCHEMBL8796929

CC1=C(C(=Cc2ccc([S+](C)[O-])cc2)C(=O)O)c2cc(N(C)C)ccc2C1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 2/20 0.34
▸ MAOB P27338 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.30
▸ LMNA P02545 2/20 0.30
▸ MAPT P10636 2/20 0.30
▸ KMT2A Q03164 2/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ JAK2 O60674 1/20 0.30
▸ MITF O75030 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ NTSR1 P30989 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ AKR1C3 P42330 2/20 0.30
▸ PTGS2 P35354 2/20 0.30
▸ GAA P10253 1/20 0.30
▸ PTGS1 P23219 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15571625 0.87 AKR1C3 (0.37) MAOAMAOBAKR1C3PTGS2
SCHEMBL15570939 0.87 PTGS2 (0.37) MAOAMAOBAKR1C3PTGS2
SCHEMBL2223120 0.85 PTGS2 (0.38) MAOAMAOBALDH1A1MAPTKMT2A
SCHEMBL8506321 0.85 PTGS2 (0.38) MAOAMAOBALDH1A1MAPTKMT2A
SCHEMBL2221809 0.85 AKR1C3 (0.37) MAOAMAOBALDH1A1AKR1C3PTGS2
SCHEMBL2223831 0.85 PTGS2 (0.32) AKR1C3PTGS2
SCHEMBL8796288 0.84 AKR1C3 (0.48) AKR1C3PTGS2
SCHEMBL15572432 0.84 PTGS2 (0.34) ALDH1A1KMT2AMEN1AKR1C3PTGS2
SCHEMBL15570465 0.84 AKR1C3 (0.39) MAOBALDH1A1KMT2AMEN1AKR1C3
SCHEMBL8797000 0.83 AKR1C3 (0.45) MAOAMAOBALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0723442-A4 LACTONE COMPOUNDS FOR TREATING PATIENTS WITH PRECANCEROUS LESIONS CELL PATHWAYS INC (US) 1997-06-11 — — EP disclosed
EP-0723442-A1 LACTONE COMPOUNDS FOR TREATING PATIENTS WITH PRECANCEROUS LESIONS CELL PATHWAYS, INC. (US) 1996-07-31 — — EP disclosed
WO-1996003987-A1 LACTONE COMPOUNDS FOR TREATING PATIENTS WITH PRECANCEROUS LESIONS CELL PATHWAYS, INC. (US) 1996-02-15 — — WO disclosed
Send feedback